PAUL L KAUFMAN, MD
Medical Practice at Harvard Dr, Madison, WI
License number
Wisconsin 19748
Category
Medical Practice
Type
Ophthalmology
Address
Address
3006 Harvard Dr, Madison, WI 53705
Phone
(608) 238-0590
Organization information
See more information about PAUL L KAUFMAN at bizstanding.comUniversity Station Clinic - Paul L Kaufman MD
2880 University Ave #U192, Madison, WI 53705
Categories:
Ophthalmology Physicians & Surgeons, Physicians & Surgeons
Site:
Phone:
(608) 263-6070 (Phone)
Products:
A National Leader in Eye Care, Eye Examinations and Contact Lens Fitting, For Ophthalmology Exam Questions and Appointment Scheduling, Please Refer To the Ophthalmology Phone Numbers Listed On the Tab Located at the Physicians & Surgeons, ...
Additional:
Optical Shops, Madison Eye Associates
Professional information
Cytoskeletal Active Agents For Glaucoma Therapy
US Patent:
6586425, Jul 1, 2003
Filed:
Jan 29, 2001
Appl. No.:
09/772412
Inventors:
Paul L. Kaufman - Madison WI
Benjamin Geiger - Rehovot, IL
Benjamin Geiger - Rehovot, IL
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
Yeda Research and Development Co., Ltd. - Rehovot
Yeda Research and Development Co., Ltd. - Rehovot
International Classification:
A61K 3155
US Classification:
514218, 514456, 514912, 514913
Abstract:
Methods for the treatment of glaucoma are provided by the present invention. The compounds described cause a perturbation of the actin cytoskeleton in the trabecular meshwork or the modulation of its interactions with the underlying membrane. Perturbation of the cytoskeleton and the associated adhesions reduces the resistance of the trabecular meshwork to fluid flow and thereby reduces intraocular pressure.
Cytoskeletal Active Agents For Glaucoma Therapy
US Patent:
6110912, Aug 29, 2000
Filed:
Feb 11, 1998
Appl. No.:
9/022228
Inventors:
Paul L. Kaufman - Madison WI
Benjamin Geiger - Rehovot, IL
Benjamin Geiger - Rehovot, IL
Assignee:
Wisconsin Alumni Research Foundation - WI
Yeda Research And Development Co., Ltd.
Yeda Research And Development Co., Ltd.
International Classification:
A61K 3155
US Classification:
514218
Abstract:
Methods for the treatment of glaucoma are described. The compounds described cause a perturbation of cell adhesions in the trabecular meshwork, mainly via disruption of the associated cytoskeletal structures or the modulation of their interactions with the underlying membrane. Perturbation of these adhesions reduces the resistance of the trabecular meshwork to fluid flow and thereby reduces intraocular pressure.
Cytoskeletal Active Agents For Glaucoma Therapy
US Patent:
5798380, Aug 25, 1998
Filed:
Feb 21, 1996
Appl. No.:
8/604568
Inventors:
Paul L. Kaufman - Madison WI
Benjamin Geiger - Rehovot, IL
Benjamin Geiger - Rehovot, IL
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A67K 3135
US Classification:
514456
Abstract:
Methods for the treatment of glaucoma are described. The compounds described cause a perturbation of cell adhesions in the trabecular meshwork, mainly via disruption of the associated cytoskeletal structures or the modulation of their interactions with the underlying membrane. Perturbation of these adhesions reduces the resistance of the trabecular meshwork to fluid flow and thereby reduces intraocular pressure.
Agent And Method For Reducing Intraocular Pressure
US Patent:
2004017, Sep 9, 2004
Filed:
Oct 18, 2002
Appl. No.:
10/240488
Inventors:
Donna Peters - Middleton WI, US
Paul Kaufman - Madison WI, US
Paul Kaufman - Madison WI, US
International Classification:
A61K038/48, C12N005/08
US Classification:
424/094630, 435/368000
Abstract:
A method for reducing cell contacts and matrix organization in trabecular meshwork of a human or nonhuman eye includes the step of administering a suitable peptide having a sequence found in the Hep II domain of fibronectin where the peptide has an ability to disrupt cell contacts and matrix formation. A result of the disruption is reduced intraocular pressure in the treated eye.
Professor And Chair At Uw School Of Medicine And Public Health
Position:
Professor and Chair at UW School of Medicine and Public Health
Location:
Madison, Wisconsin Area
Industry:
Hospital & Health Care
Work:
UW School of Medicine and Public Health
since 2012
-
Professor and Chair
Vitamin D Compounds And Methods For Reducing Ocular Hypertension (Oht)
US Patent:
2011005, Mar 10, 2011
Filed:
Mar 10, 2009
Appl. No.:
12/921497
Inventors:
Hector F. DeLuca - Deerfield WI, US
Galina D. Kutuzova - Madison WI, US
Paul L. Kaufman - Madison WI, US
B'Ann True Gabelt - Madison WI, US
Galina D. Kutuzova - Madison WI, US
Paul L. Kaufman - Madison WI, US
B'Ann True Gabelt - Madison WI, US
International Classification:
A61K 31/593, A61K 31/59, A61P 27/02, A61P 27/06, C07C 401/00
US Classification:
514167, 552653
Abstract:
The present invention relates to compounds and methods for reducing intraocular pressure and treating ocular hypertension in a subject.
Paul Leon Kaufman, Madison WI
Specialties:
Ophthalmology
Work:
Clnc. SCI. Ctr Ophthal
600 Highland Ave, Madison, WI 53792
600 Highland Ave, Madison, WI 53792
Education:
New York University (1967)
Dr. Paul L Kaufman, Madison WI - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
2870 University Ave STE 206, Madison 53705
(608) 263-6070 (Phone)
University Of Wisconsin Hospital OPH
2880 University Ave, Madison 53705
(608) 263-6070 (Phone)
(608) 263-6070 (Phone)
University Of Wisconsin Hospital OPH
2880 University Ave, Madison 53705
(608) 263-6070 (Phone)
Certifications:
Ophthalmology, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
2870 University Ave STE 206, Madison 53705
University Of Wisconsin Hospital OPH
2880 University Ave, Madison 53705
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
University Of Wisconsin Hospital OPH
2880 University Ave, Madison 53705
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Education:
Medical School
New York University School Of Medicine
Graduated: 1967
Bellevue Hospital Center
Graduated: 1968
Wash University Barnes Hospital
Graduated: 1973
University Uppsala
Graduated: 1975
New York University School Of Medicine
Graduated: 1967
Bellevue Hospital Center
Graduated: 1968
Wash University Barnes Hospital
Graduated: 1973
University Uppsala
Graduated: 1975
Method For Reducing The Risk Of Posterior Capsular Opacification
US Patent:
2006027, Nov 30, 2006
Filed:
Apr 28, 2006
Appl. No.:
11/413470
Inventors:
Paul Kaufman - Madison WI, US
Baohe Tian - Madison WI, US
Baohe Tian - Madison WI, US
International Classification:
A61F 9/013
US Classification:
606107000, 623006560, 514912000
Abstract:
It is disclosed here that actin-disrupting compounds and 1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine can be used to facilitate the removal of lens epithelial cells from the lens capsule during cataract surgery and they may also be used to inhibit lens epithelial cells' proliferation and/or migration after surgery to reduce the risk or severity of posterior capsular opacification. Various related methods, kits, and ocular implants for reducing the risk or severity of posterior capsular opacification are provided.
Method For Treating Glaucoma
US Patent:
7083783, Aug 1, 2006
Filed:
Feb 18, 2005
Appl. No.:
11/060920
Inventors:
Paul L. Kaufman - Madison WI, US
Xuyang Liu - Madison WI, US
Xuyang Liu - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 38/45, C12N 9/12
US Classification:
424 945, 435193, 4352523, 4353201, 536 232
Abstract:
A method for increasing outflow facility and reducing intraocular pressure from an eye of a subject having glaucoma includes the step of administering to the eye an amount of an ADP ribosyltransferase protein effective to reduce intraocular pressure and increase outflow facility.